Development and Validation of Non-Invasive Immune Imaging Technology to Accelerate the Development of Beta Cell Replacement Therapies



Topic: Diabetes.

Destination: JDRF seeks applications to support preclinical and clinical research into the development and in vivo validation of medical imaging technology for non-invasive in vivo monitoring of immune responses to transplanted insulin-producing cells. These technologies provide a unique opportunity to elucidate the mechanisms of immune rejection by enabling non-invasive longitudinal assessments and tracking of immune cell activation, trafficking, and targeting of the beta cell graft.

Budget: $750,000.

Duration: 3 years.

Are you interested in this call?

Estás interesado?

Llena el siguiente formulario para recibir más información: